EDSA · Edesa Biotech Inc
United States · RS rating 18 · As of 2026-10-14
| Price | 2.65 USD |
|---|---|
| 1-day change | -7.0% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 4 / 3 / 53 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 24 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -75.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +85.5% |
| Market cap (USD) | $60.2M |